BGH’s Revised Higher Offer for Virtus
BGH has returned with a revised offer of $7.65 per share, which is 7.7% higher than BGH’s original offer of A$7.10. CapVest’s (rival suitor) best...
355 Views
Virtus Receives a Competing Offer from CapVest
CapVest's offer comprises A$7.60 via a scheme (7.0% premium to BGH’s A$7.10 offer) or A$7.50 via an off-market takeover. Due to the healthy...
345 Views
Virtus Receives a A$7.10 Per Share Offer from BGH Capital
BGH Capital has lobbed a non-binding A$7.10 cash per share offer, a 36.3% premium to the unaffected price. The offer is reasonable in the context...
317 Views
Jinxin Fertility Group IPO: Valuation Reasonable for the Trade-Offs
Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. It announced its IPO price...
1.1k Views
Healius (HLS AU): An Unattractive Bid
Healius (HLS AU), formerly known as Primary Health Care (PRY AU), is a leading Australian owner of GP clinics and pathology centres. On 3 January...
778 Views